NCT00316407 - Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Ovarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer

Interventions

DRUG

lapatinib (GW572016)

1000 mg po qd

DRUG

Carboplatin

AUC 2 weekly x 3 of 4 week cycle

DRUG

Paclitaxel

60 mg/m2 weekly x 3 of 4 week cycle

Trial Locations (2)

University of New Mexico Cancer Center, Albuquerque

Swedish Medical Center Cancer Institute, Seattle